# Targeting Complement 5a-Mediated Immunoregulation for Neurofibroma Therapy

> **NIH NIH R33** · CINCINNATI CHILDRENS HOSP MED CTR · 2022 · $391,227


## Key facts

- **NIH application ID:** 10400915
- **Project number:** 5R33NS112407-03
- **Recipient organization:** CINCINNATI CHILDRENS HOSP MED CTR
- **Principal Investigator:** NANCY RATNER
- **Activity code:** R33 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $391,227
- **Award type:** 5
- **Project period:** 2019-09-01 → 2023-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10400915

## Citation

> US National Institutes of Health, RePORTER application 10400915, Targeting Complement 5a-Mediated Immunoregulation for Neurofibroma Therapy (5R33NS112407-03). Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/grant/nih/10400915. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*